ID   EL4.IL-2
AC   CVCL_5681
SY   EL4-IL2
DR   CLO; CLO_0002917
DR   ATCC; TIB-181
DR   BCRC; 60275
DR   CCRID; 3101MOUTCM21
DR   CLS; 400425
DR   Wikidata; Q54832237
RX   PubMed=6968789;
RX   PubMed=34737324;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Characteristics: Produces IL2 in response to phorbol-12-myristate-13-acetate (PMA).
CC   Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 19
//
RX   PubMed=6968789; DOI=10.4049/jimmunol.125.6.2555;
RA   Farrar J.J., Fuller-Farrar J., Simon P.L., Hilfiker M.L.,
RA   Stadler B.M., Farrar W.L.;
RT   "Thymoma production of T cell growth factor (interleukin 2).";
RL   J. Immunol. 125:2555-2558(1980).
//
RX   PubMed=34737324; DOI=10.1038/s41598-021-00779-5;
RA   Lung O., Candlish R.C., Nebroski M., Kruckiewicz P., Buchanan C.,
RA   Moniwa M.;
RT   "High-throughput sequencing for species authentication and
RT   contamination detection of 63 cell lines.";
RL   Sci. Rep. 11:21657-21657(2021).
//